<!DOCTYPE html >
<html lang="en">
<head>
<meta http-equiv="X-UA-Compatible" content="IE=Edge" />
<meta charset="utf-8" />
</head>

<body style="margin: 0;">

<div id="p158" style="overflow: hidden; position: relative; background-color: white; width: 433px; height: 649px;">

<!-- Begin shared CSS values -->
<style class="shared-css" type="text/css" >
.t {
	-webkit-transform-origin: top left;
	-moz-transform-origin: top left;
	-o-transform-origin: top left;
	-ms-transform-origin: top left;
	-webkit-transform: scale(0.25);
	-moz-transform: scale(0.25);
	-o-transform: scale(0.25);
	-ms-transform: scale(0.25);
	z-index: 2;
	position: absolute;
	white-space: pre;
	overflow: visible;
}
</style>
<!-- End shared CSS values -->


<!-- Begin inline CSS -->
<style type="text/css" >

#t1_158{left:4px;top:233px;letter-spacing:-0.1px;}
#t2_158{left:4px;top:78px;letter-spacing:-0.3px;}
#t3_158{left:5px;top:629px;letter-spacing:-0.3px;}
#t4_158{left:52px;top:40px;letter-spacing:-1px;word-spacing:1.2px;}
#t5_158{left:52px;top:56px;letter-spacing:-1px;word-spacing:4.7px;}
#t6_158{left:52px;top:71px;letter-spacing:-1px;word-spacing:4.8px;}
#t7_158{left:52px;top:86px;letter-spacing:-1px;word-spacing:-0.1px;}
#t8_158{left:52px;top:104px;letter-spacing:-1px;}
#t9_158{left:59px;top:104px;letter-spacing:-1px;}
#ta_158{left:136px;top:104px;letter-spacing:-1px;word-spacing:-0.5px;}
#tb_158{left:59px;top:119px;letter-spacing:-1px;word-spacing:-2.1px;}
#tc_158{left:59px;top:134px;letter-spacing:-1px;word-spacing:-0.6px;}
#td_158{left:332px;top:134px;}
#te_158{left:338px;top:134px;letter-spacing:-1px;}
#tf_158{left:43px;top:169px;letter-spacing:-1px;}
#tg_158{left:54px;top:169px;letter-spacing:-1px;word-spacing:-0.1px;}
#th_158{left:52px;top:186px;letter-spacing:-1px;}
#ti_158{left:59px;top:186px;letter-spacing:-1px;}
#tj_158{left:133px;top:186px;letter-spacing:-1px;word-spacing:1px;}
#tk_158{left:59px;top:202px;letter-spacing:-0.9px;word-spacing:4.5px;}
#tl_158{left:59px;top:217px;letter-spacing:-1px;word-spacing:-0.1px;}
#tm_158{left:52px;top:234px;letter-spacing:-1px;}
#tn_158{left:59px;top:234px;letter-spacing:-1px;word-spacing:8.7px;}
#to_158{left:253px;top:234px;letter-spacing:-0.9px;word-spacing:8.6px;}
#tp_158{left:59px;top:250px;letter-spacing:-1px;word-spacing:1.8px;}
#tq_158{left:59px;top:265px;letter-spacing:-1px;word-spacing:-0.1px;}
#tr_158{left:43px;top:300px;letter-spacing:-0.9px;word-spacing:-0.3px;}
#ts_158{left:52px;top:317px;letter-spacing:-1px;}
#tt_158{left:59px;top:317px;letter-spacing:-1px;word-spacing:3.1px;}
#tu_158{left:59px;top:333px;letter-spacing:-1px;word-spacing:6.3px;}
#tv_158{left:202px;top:333px;}
#tw_158{left:214px;top:333px;letter-spacing:-1px;word-spacing:6.2px;}
#tx_158{left:59px;top:348px;letter-spacing:-1px;word-spacing:-0.1px;}
#ty_158{left:52px;top:365px;letter-spacing:-1px;}
#tz_158{left:59px;top:365px;letter-spacing:-1px;word-spacing:-0.2px;}
#t10_158{left:126px;top:365px;}
#t11_158{left:133px;top:365px;letter-spacing:-1px;word-spacing:-0.1px;}
#t12_158{left:52px;top:383px;letter-spacing:-1px;}
#t13_158{left:59px;top:383px;letter-spacing:-1px;word-spacing:4.4px;}
#t14_158{left:59px;top:398px;letter-spacing:-1px;word-spacing:5.9px;}
#t15_158{left:59px;top:413px;letter-spacing:-1px;}
#t16_158{left:52px;top:431px;letter-spacing:-1px;}
#t17_158{left:59px;top:431px;letter-spacing:-1px;word-spacing:-2px;}
#t18_158{left:59px;top:446px;letter-spacing:-1px;}
#t19_158{left:81px;top:446px;letter-spacing:-1px;word-spacing:-1.1px;}
#t1a_158{left:143px;top:446px;letter-spacing:-0.9px;word-spacing:-1px;}
#t1b_158{left:59px;top:461px;letter-spacing:-1px;word-spacing:-0.1px;}
#t1c_158{left:52px;top:479px;letter-spacing:-1px;word-spacing:-0.2px;}
#t1d_158{left:234px;top:479px;}
#t1e_158{left:241px;top:479px;letter-spacing:-1px;}
#t1f_158{left:52px;top:496px;letter-spacing:-1px;}
#t1g_158{left:59px;top:496px;letter-spacing:-1px;}
#t1h_158{left:114px;top:496px;letter-spacing:-0.9px;word-spacing:-0.1px;}
#t1i_158{left:52px;top:514px;letter-spacing:-1px;word-spacing:-2px;}
#t1j_158{left:52px;top:529px;letter-spacing:-1px;word-spacing:-0.1px;}
#t1k_158{left:52px;top:546px;letter-spacing:-1px;}
#t1l_158{left:59px;top:546px;letter-spacing:-1.2px;}
#t1m_158{left:134px;top:546px;letter-spacing:-1.2px;word-spacing:10.3px;}
#t1n_158{left:59px;top:562px;letter-spacing:-1.2px;word-spacing:-0.1px;}
#t1o_158{left:52px;top:579px;letter-spacing:-1px;}
#t1p_158{left:59px;top:579px;letter-spacing:-1px;}
#t1q_158{left:123px;top:579px;letter-spacing:-1px;}

.s1_158{
	FONT-SIZE: 48.9px;
	FONT-FAMILY: AllerDisplay_lq;
	color: rgb(156,100,158);
}

.s2_158{
	FONT-SIZE: 48.9px;
	FONT-FAMILY: AllerDisplay_lq;
	color: rgb(35,31,32);
}

.s3_158{
	FONT-SIZE: 39.7px;
	FONT-FAMILY: AllerDisplay_lq;
	color: rgb(255,255,255);
}

.s4_158{
	FONT-SIZE: 48.9px;
	FONT-FAMILY: Helvetica-Condensed_ix;
	color: rgb(35,31,32);
}

.s5_158{
	FONT-SIZE: 48.9px;
	FONT-FAMILY: Helvetica-Condensed-Bold_j0;
	color: rgb(35,31,32);
}

.s6_158{
	FONT-SIZE: 48.9px;
	FONT-FAMILY: Symbol_j9;
	color: rgb(35,31,32);
}

.s7_158{
	FONT-SIZE: 48.9px;
	FONT-FAMILY: DINPro-Medium_k5;
	color: rgb(35,31,32);
}

.s8_158{
	FONT-SIZE: 48.9px;
	FONT-FAMILY: ArialMT_kg;
	color: rgb(35,31,32);
}

.s9_158{
	FONT-SIZE: 48.9px;
	FONT-FAMILY: HelveticaNeue-LightCondOb_j8;
	color: rgb(35,31,32);
}

.t.m0_158{
	-webkit-transform: matrix(0,-1,1,0,0, 0) scale(0.25);
	-ms-transform: matrix(0,-1,1,0,0, 0) scale(0.25);
	-moz-transform: matrix(0,-1,1,0,0, 0) scale(0.25);
	-o-transform: matrix(0,-1,1,0,0, 0) scale(0.25);
}

</style>
<!-- End inline CSS -->

<!-- Begin embedded font definitions -->
<style id="fonts158" type="text/css" >

@font-face {
	font-family: DINPro-Medium_k5;
	src: url("fonts/DINPro-Medium_k5.woff") format("woff");
}

@font-face {
	font-family: ArialMT_kg;
	src: url("fonts/ArialMT_kg.woff") format("woff");
}

@font-face {
	font-family: Symbol_j9;
	src: url("fonts/Symbol_j9.woff") format("woff");
}

@font-face {
	font-family: HelveticaNeue-LightCondOb_j8;
	src: url("fonts/HelveticaNeue-LightCondOb_j8.woff") format("woff");
}

@font-face {
	font-family: Helvetica-Condensed-Bold_j0;
	src: url("fonts/Helvetica-Condensed-Bold_j0.woff") format("woff");
}

@font-face {
	font-family: AllerDisplay_lq;
	src: url("fonts/AllerDisplay_lq.woff") format("woff");
}

@font-face {
	font-family: Helvetica-Condensed_ix;
	src: url("fonts/Helvetica-Condensed_ix.woff") format("woff");
}

</style>
<!-- End embedded font definitions -->

<!-- Begin page background -->
<div id="pg158Overlay" style="width:100%; height:100%; position:absolute; z-index:1; background-color:rgba(0,0,0,0); -webkit-user-select: none;"></div>
<div id="pg158" style="-webkit-user-select: none;"><object width="433" height="649" data="158/158.svg" type="image/svg+xml" id="pdf158" style="width:433px; height:649px; -moz-transform:scale(1); z-index: 0;"></object></div>
<!-- End page background -->


<!-- Begin text definitions (Positioned/styled in CSS) -->
<div id="t1_158" class="t m0_158 s1_158">O Guia do Jovem Internista </div>
<div id="t2_158" class="t m0_158 s2_158">2016</div>
<div id="t3_158" class="t s3_158">156</div>
<div id="t4_158" class="t s4_158">Os colóides aumentam mais rapidamente a volémia e promovem re-</div>
<div id="t5_158" class="t s4_158">tenção de fluidos no espaço intravascular mas não há estudos que </div>
<div id="t6_158" class="t s4_158">demonstrem a sua vantagem em relação aos cristalóides, podendo </div>
<div id="t7_158" class="t s4_158">aumentar a mortalidade nos doentes com traumatismos graves</div>
<div id="t8_158" class="t s5_158">- </div>
<div id="t9_158" class="t s5_158">Hemoderivados</div>
<div id="ta_158" class="t s4_158">se há perdas hemorrágicas continuadas com dimi-</div>
<div id="tb_158" class="t s4_158">nuição progressiva da hemoglobina transfundir se Hb&lt;10g/dL. Após </div>
<div id="tc_158" class="t s4_158">estabilização e hemorragia controlada não transfundir se Hb</div>
<div id="td_158" class="t s6_158">±</div>
<div id="te_158" class="t s4_158">7g/dL.</div>
<div id="tf_158" class="t s5_158">• </div>
<div id="tg_158" class="t s5_158">Suporte aminérgico:</div>
<div id="th_158" class="t s4_158">- </div>
<div id="ti_158" class="t s5_158">Noradrenalina:</div>
<div id="tj_158" class="t s4_158">iniciar perfusão como medida de suporte enquanto </div>
<div id="tk_158" class="t s4_158">se estão a repor os fluidos perdidos, de maneira a suportar a TA. </div>
<div id="tl_158" class="t s4_158">Não usar após a volémia estar reposta.</div>
<div id="tm_158" class="t s4_158">- </div>
<div id="tn_158" class="t s5_158">Dobutamina, dopamina, vasopressina:</div>
<div id="to_158" class="t s4_158">no caso de hipovolémia </div>
<div id="tp_158" class="t s4_158">prolongada e grave pode ser necessário, após a reposição da volé-</div>
<div id="tq_158" class="t s4_158">mia, melhorar inotropismo.</div>
<div id="tr_158" class="t s5_158">• Choque cardiogénico</div>
<div id="ts_158" class="t s4_158">- </div>
<div id="tt_158" class="t s4_158">Avaliação rápida e correcção da causa: isquémia, bradiarritmia, ta-</div>
<div id="tu_158" class="t s4_158">quidisritmia, tamponamento…</div>
<div id="tv_158" class="t s7_158">→</div>
<div id="tw_158" class="t s4_158">ECG e monitorização; ecocardio-</div>
<div id="tx_158" class="t s4_158">grama se possível; Rx e análises</div>
<div id="ty_158" class="t s4_158">- </div>
<div id="tz_158" class="t s4_158">Parar nitratos, </div>
<div id="t10_158" class="t s8_158">²</div>
<div id="t11_158" class="t s4_158">-bloqueantes, IECA’s…</div>
<div id="t12_158" class="t s4_158">- </div>
<div id="t13_158" class="t s4_158">Ventilação não invasiva (CIPAP, BIPAP) ou invasiva se necessário </div>
<div id="t14_158" class="t s4_158">para diminuir o trabalho cardíaco, melhorar oxigenação e corrigir </div>
<div id="t15_158" class="t s4_158">acidose.</div>
<div id="t16_158" class="t s4_158">- </div>
<div id="t17_158" class="t s4_158">Optimizar pré-carga: nos doentes SEM EDEMA PULMONAR AGUDO </div>
<div id="t18_158" class="t s4_158">usar </div>
<div id="t19_158" class="t s9_158">ﬂuid challenge</div>
<div id="t1a_158" class="t s4_158">cauteloso (SF 500ml em 30’); se melhoria manter </div>
<div id="t1b_158" class="t s4_158">aporte de fluidos mais lento</div>
<div id="t1c_158" class="t s4_158">- Optimizar inotropismo (objectivo PAM</div>
<div id="t1d_158" class="t s6_158">±</div>
<div id="t1e_158" class="t s4_158">60mmHg)</div>
<div id="t1f_158" class="t s4_158">- </div>
<div id="t1g_158" class="t s5_158">Dopamina:</div>
<div id="t1h_158" class="t s4_158">primeira escolha em doentes com PAS&lt;90mmHg. </div>
<div id="t1i_158" class="t s4_158">Iniciar com 2-5 μg/kg/min (dose vasopressora e cronotrópica) e esca-</div>
<div id="t1j_158" class="t s4_158">lar cada 2-5 minutos até 20-50 μg/kg/min</div>
<div id="t1k_158" class="t s4_158">- </div>
<div id="t1l_158" class="t s5_158">Noradrenalina:</div>
<div id="t1m_158" class="t s4_158">se hipotensão refractária; iniciar a 2-4μg/min até </div>
<div id="t1n_158" class="t s4_158">15μg/min (não há vantagem em escalar a dose acima deste valor)</div>
<div id="t1o_158" class="t s4_158">- </div>
<div id="t1p_158" class="t s5_158">Dobutamina:</div>
<div id="t1q_158" class="t s4_158">3-15μg/kg/min</div>

<!-- End text definitions -->


</div>
</body>
</html>
